Legal Marijuana is the fastest growing industry in the United States. In 2016, cannabis sales in North America went up 30% from 2015 to reach $6.7 billion.
And looking into the future with more states, Canada and countries around the world making their way toward legalization this already extraordinary speed of growth is actually set to pick up.
Kush Bottles, Inc. (OTCQB: KSHB), a dynamic sales and distribution platform that provides unique products and services to both businesses and consumers in the regulated cannabis industry, has hired a new sales and support team
Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) announces the proposed offering of up to 80 million share purchase warrants. Each warrant will be offered for a consideration of 10 cents (CDN) per warrant for a total of gross proceeds of up to $8 million dollars and are exercisable into one common share for the price of $2.90 per share for a period of 3 years from the date of closing (the "warrants").
ABcann Global Corporation (TSX-V: ABCN ) is pleased to announce its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ ).
Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that the Company has already achieved a good number of its goals for 2017. Cannabis Science is aggressively expanding its corporate footprint in legal states throughout the USA, to help self-medicating patients with multiple critical ailments.
Aphria Inc. ( TSX:APH )( OTCQB:APHQF ), through its subsidiary Pure Natures Wellness Inc. (o/a Aphria), is pleased to announce that it entered into a major wholesale supply agreement with HydRx Farms, Ltd. (o/a Scientus Pharma).
Tokyo Smoke to open Canadian flagship retail store on Queen Street West July 20. 1,000 square foot space, designed by DesignAgency, to offer coffee, carefully selected cannabis accessories, apparel and exclusive Queen West merchandise and perk-filled, unlimited coffee membership
New research shows that cannabis can not only treat migraines and cluster headaches, but do so more effectively compared to conventional treatment. Participants in the study suffered from either chronic migraines or cluster headaches. Migraines cause all-over headache pain and nausea as well as a sensitivity to light and sound. Cluster headaches typically cause pain in one area, usually within proximity to the eyes. Researchers needed to determine the actual dosage they would use in the study.
On Thursday, India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, was featured in an article on Benzinga titled ‘Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work’.
Lines are expected Saturday outside some medical marijuana dispensaries in Las Vegas and other Nevada cities that will begin selling pot for recreational use for the first time since voters approved it in November.
It’s the fastest turnaround from the ballot box to retail sales of any of the seven other states and the District of Columbia where pot is legal.
On Thursday, ABcann Global Corporation (TSXV: ABCN) announced that it has retained the services of Dr. Michael Shannon as its chief medical consultant.
Premier Biomedical, Inc. (OTCQB: BIEI), a research-based company focused on the discovery and development of medical treatments for a wide range of diseases, this morning announced that it has reached an agreement with specialized holding company SinglePoint, Inc. (OTC: SING) to manufacture Premier’s new-design CBD Hemp Oil Patch in high volume.
ABcann Global Corporation (TSX-V: ABCN ) is pleased to announce that it has retained the services of Dr. Michael Shannon as its Chief Medical Consultant. Dr. Shannon served in the Canadian Armed Forces for 31 years, and also as Deputy Surgeon General for Canada.
HelloMD, one of the nation's largest community of medical cannabis patients, today announced the results of their landmark study examining the use of cannabis as a substitute for opiate and non-opiate based pain medication.
Aurora Cannabis Inc. (ACB.V) (ACBFF) (Frankfurt:21P; WKN:A1C4WM) and WeedMD Inc. (“WeedMD”) (WMD.V) are pleased to announce that the companies have entered into a strategic relationship whereby WeedMD will provide wholesale dried medical cannabis to Aurora, and Aurora will provide best in class patient education services for WeedMD through its cannabis counselling and outreach unit CanvasRx.
